Editorial

SYNTAXES, biomarkers and survival in complex coronary artery disease: the intervention of secondary prevention

EuroIntervention 2022;17:1460-1462. DOI: 10.4244/EIJ-E-22-00008

Martha Gulati
Martha Gulati1, MD, MS, FESC, FACC, FAHA, FASPC, SCAI-ELM; Sonya Burgess2,3, MBChB, PhD, FRACP, FCSANZ, SCAI-ELM
1. Division of Cardiology, University of Arizona, Phoenix, AZ, USA; 2. University of Sydney, Nepean Hospital, Sydney, Australia; 3. Division of Cardiology, Sydney Southwest Hospital, Sydney, Australia
It is easy to imagine that the most important decisions made while caring for patients with multivessel disease or left main coronary artery disease (CAD) are made in the coronary catheterisation laboratory. There, critical decisions occur, including the determination of the optimal revascularisation strategy and the timing of revascularisation, with the appropriate focus on anatomical complexity and burden of disease. Implementing the best evidence and revascularisation guidelines, incorporating imaging and appropriate bifurcation strategies, in addition to determining the duration of dual antiplatelet therapy are all essential to ensure the best long-term outcomes. These complex patients require a well-trained, multidisciplinary high-risk ...

Sign in to read and download the full article

Forgot your password?

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Picture perfect? Performance of quantitative coronary angiography-based vessel FFR versus pressure wire-based FFR

Latest news